# Rewinding RX reviews (2026): GLP-1 telehealth sellers | This GLP A fixed figure at any dose, four strengths listed, and no membership. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/rewinding-rx Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Fixed price, any dose # Rewinding RX review A fixed figure at any dose, four strengths listed, and no membership. ## The verdict Rewinding RX publishes $139 a month for compounded semaglutide and $189 for tirzepatide. Both are fixed at any dose, with no hidden fees or memberships. Fifty states are covered. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection Dose pricing Flat across doses States 50 From From $139/mo Prescription Required Compounded Yes — not FDA-approved Availability All 50 states Rewinding RX sells both molecules by injection. Doses of 0.25, 1.5, 2 and 2.5 mg are listed, or a custom dose. Cancellation is stated as available anytime. 1. ## Who writes the prescription, and what do they see? A prescription precedes shipping. A custom dose option implies a clinical decision. The clinician is not described. Three terms are stated together: fixed price, cancel anytime, no memberships. Each is checkable and each removes a common surprise. 2. ## What happens when the dose goes up? Four strengths are listed at one figure and a custom dose is offered. That answers the price question across the published range and leaves the custom case open. 3. ## What the price includes Six months at $139 is $834 and tirzepatide at $189 is $1,134. Both totals hold at any listed dose. Nothing is described as sitting outside either figure. 4. ## What it claims, and what it cites Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named. ## Where it holds up, and where it does not - Strength: Fixed price at any listed dose - Strength: Four strengths published - Strength: No memberships or hidden fees - Strength: Coverage across all fifty states - Limitation: A custom dose is not priced - Limitation: No compounding pharmacy is named - Limitation: No first-month figure published ## What the evidence says about this kind of treatment The assessment above is about Rewinding RX. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who wants a fixed figure and the doses it covers listed. Wrong for A reader needing a custom dose priced in advance. ## The evidence behind what Rewinding RX prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Rewinding RX compares | Seller | Who it suits | Go | | --- | --- | --- | | Revel RX | A reader drawn to a low flat rate who also wants the handling described | | | Renlo Health | Readers who want the flat claim shown at each tier rather than asserted once | | | REMEVi | Readers committing a year who want the rate fixed through titration | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Liv Body](https://thisglp.com/reviews/liv-body) [LIV by WellNow](https://thisglp.com/reviews/liv-by-wellnow) [Livea](https://thisglp.com/reviews/livea) [50 Stars Health](https://thisglp.com/reviews/livv) [Longevixx](https://thisglp.com/reviews/longevixx) [Loop Health](https://thisglp.com/reviews/loop-health) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Which doses does $139 cover? 0.25, 1.5, 2 and 2.5 mg are listed. A custom dose is offered without a published figure. Is there a membership? No. The site states no hidden fees or memberships, and cancellation at any time. What does tirzepatide cost? $189 a month on the same fixed-price terms. Is Rewinding RX legit? Rewinding RX is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay. Is Rewinding RX expensive compared with other GLP-1 telehealth sellers? Rewinding RX publishes a starting figure of $139/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Rewinding RX below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).